Sulfacetamide
Indications
Registered South African indications:
- Infection of the eye and eye socket
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to sulphonamides
- Penetrating wounds of the cornea
- Coadministration with agents containing silver salts
Cautions
- Pregnancy
- Breastfeeding
Adult dosage
Forms avail. in SA and covered in this monograph: oin
Infection of the eye and eye socket
Stye
Trachoma
- Topical (oin): Apply small quantity into the inner corner of the affected eye, 3 times daily
For external use only. Doctor consultation required if no improvement has occurred within a few days
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: oin
Infection of the eye and eye socket
Stye
Trachoma
Younger than 2 months
- Not established for use
Older than 2 months
- See adult dosage
Special populations
Pregnancy
- Caution
- No animal studies have been performed. There are limited/no data on the extent of systemic absorption following ophthalmic use. Sulfonamides have been associated with kernicterus in infants born to mothers who used systemic sulfonamides during their pregnancy
Breastfeeding
- Caution; not recommended
- There are limited/no data on the extent of systemic absorption following ophthalmic use. Sulfonamides have been associated with kernicterus in breastfeeding infants whose mothers are administered with systemic sulfonamides. Breastfeeding is not recommended when administering sulfacetamide to the mother. When considering the use of sulfacetamide in breastfeeding mothers, any benefits of treatment of the mother should outweigh the potential risks to the mother and infant
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Cardiovascular Disorders
- Oedema
Skin and Subcutaneous Tissue Disorders
- Rash
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Systemic lupus erythematosus
Sensory Disorders
- Burning eyes
- Stinging eyes
- Conjunctival hyperaemia
- Conjunctivitis
- Corneal ulceration
- Eye irritation
Interactions
Silver preparations
Monitoring
None routine
Mechanism of action
Sulfacetamide is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics. They work by competitively inhibiting bacterial para-aminobenzoic acid, an essential component for bacterial growth.
Dosage forms
- Eye ointment
Formulation
Eye ointment (per 3.5g) 350mg
- Lennon-Sulphacetamide (Pharmacare)
References
1. SAMF_11th Edition_Page 573 2. https://drive.google.com/drive/folders/1qrC0WSHdSHcnDvPhF7MoKYpXGt_nSOgd (06/12/1974_Pharmacare_ Sulphacetamide_eye oint) 3. https://www.drugs.com/pregnancy/sulfacetamide-sodium-ophthalmic.html (as accessed on 1/6/2017) 4. U2D: Sulfacetamide (ophthalmic): Drug information; Uptodate [https://www.uptodate.com/contents/sulfacetamide-ophthalmic-drug-information?search=sulfacetamide&source] 5. NAPOS The Drug Database for Acute Porphyria: S01AB04 Sulfacetamide; Accessed online 10 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=S01AB04] 6. South African Institute for Drug-Free Sport: Lennon-Sulphacetamide; Accessed online 10 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/] 7. PI - Lennon sulphacetamide eye ointment - Aspen - Date of most recent authorisation - 27 May 1999 - Downloaded on SAHPRA OTC on 04 December 2024 [https://medsinfoportal.sahpra.org.za/pi/766faad01ba233054e14058aa5a9c7be.pdf] **No SPC available
Brands & products
2 products · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days olddropsGeneric· 1 product
from R6.11/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Covancaine 20ml | 10 mg | 20 | S2 | R122.13 | R6.11 | R54.14 | 716596008 |
eye ointmentGeneric· 1 product
from R25.23/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Lennon Sulphacetamide Eye Ointment 3.5g | 350 mg/3.5g | 3 | S2 | R75.69 | R25.23 | R38.07 | 767360001 |
- Lennon-Sulphacetamide
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.